| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/27/2001 | WO2001098534A2 Matrix screening method |
| 12/27/2001 | WO2001098532A1 Enzyme detection and measurement |
| 12/27/2001 | WO2001098531A1 Resazurin-based cytotoxicity assay |
| 12/27/2001 | WO2001098530A2 Interaction of tbx2 and the arf promoter in cell cycle regulator assays |
| 12/27/2001 | WO2001098528A2 Method for detecting cytosine methylations |
| 12/27/2001 | WO2001098526A2 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants |
| 12/27/2001 | WO2001098525A2 Frozen tissue microarrays and methods for using the same |
| 12/27/2001 | WO2001098524A2 Protein-protein interactions |
| 12/27/2001 | WO2001098512A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | WO2001098508A2 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | WO2001098499A1 Antigenic polypeptides |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098486A1 Mutation associated with epilepsy |
| 12/27/2001 | WO2001098471A2 Human phosphodiesterases |
| 12/27/2001 | WO2001098468A2 Proteases |
| 12/27/2001 | WO2001098458A2 Methods for immobilizing polypeptides |
| 12/27/2001 | WO2001098457A2 Surface model of a protein |
| 12/27/2001 | WO2001098366A2 Enterokinase cleavage sequences and their use |
| 12/27/2001 | WO2001098360A2 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | WO2001098359A2 Cyr61 as a target for treatment and diagnosis of breast cancer |
| 12/27/2001 | WO2001098357A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | WO2001098355A2 Cgi-69 compositions and methods of use |
| 12/27/2001 | WO2001098354A2 Human receptors |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098351A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001097846A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 12/27/2001 | WO2001097845A1 Objective biochemical method for assessment of sperm quality |
| 12/27/2001 | WO2001097843A2 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | WO2001097836A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | WO2001097830A1 Modification of mdm2 activity |
| 12/27/2001 | WO2001097794A2 Inhibitors of matriptase for the treatment of cancer |
| 12/27/2001 | WO2001097770A1 Method for protecting human skin |
| 12/27/2001 | WO2001097616A1 Protein expression profiling |
| 12/27/2001 | WO2001097608A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods |
| 12/27/2001 | WO2001068901A3 Implantable analyte sensor |
| 12/27/2001 | WO2001068807A8 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme |
| 12/27/2001 | WO2001066116A8 Method for modulating tumor growth and metastasis of tumor cells |
| 12/27/2001 | WO2001064605A3 Generation and screening of a dynamic combinatorial library |
| 12/27/2001 | WO2001058338A3 A method for detecting bacterial exacerbations of chronic lung disease |
| 12/27/2001 | WO2001057507A3 Measuring device with a plunge-in electrode |
| 12/27/2001 | WO2001055721A3 Detection of biomolecules in gels following electrophoresis |
| 12/27/2001 | WO2001053830A3 Diagnostic method involving haemoglobin, haematocrit or reg blood cell count |
| 12/27/2001 | WO2001053525A3 Cell isolation method |
| 12/27/2001 | WO2001046700A3 Sodium channels as targets for amyloid beta |
| 12/27/2001 | WO2001046683A3 Total nitrogen, sulfur and chlorine analysis |
| 12/27/2001 | WO2001046256A3 Vesicle trafficking proteins |
| 12/27/2001 | WO2001044467A3 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 12/27/2001 | WO2001044438A3 Serological diagnostic method with rickettsia pulicis bacterium |
| 12/27/2001 | WO2001042503A3 Apparatus and methods for drug screening based on nucleic acid analysis |
| 12/27/2001 | WO2001042497A3 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 12/27/2001 | WO2001042488A3 Plasminogen activator assay involving an elastase inhibitor |
| 12/27/2001 | WO2001040800A3 Syk localized at centrosome |
| 12/27/2001 | WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 12/27/2001 | WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 12/27/2001 | WO2001031057A3 Double-strand nucleic acid probes and the use thereof |
| 12/27/2001 | WO2001031019A3 Neisserial antigenic peptides |
| 12/27/2001 | WO2001027618A3 A method for monitoring breast cancer chemotherapy |
| 12/27/2001 | WO2001025791A3 Prostate cancer marker proteins |
| 12/27/2001 | WO2000068419A3 Apparatus and process for monitoring and detecting small molecule-biomolecule interactions |
| 12/27/2001 | WO2000026935A8 Systems and methods for high performance scanning |
| 12/27/2001 | US20010055882 Cell patterning technique |
| 12/27/2001 | US20010055816 Urinary trypsin inhibitor assay containing a chelating agent |
| 12/27/2001 | US20010055815 Constitutive androstane receptor |
| 12/27/2001 | US20010055812 Platform for simple, flexible and accurate biological and chemical analysis |
| 12/27/2001 | US20010055810 Method and apparatus for presenting grain for nir spectography examination |
| 12/27/2001 | US20010055800 Biological analysis system comprising a means for controlling the link between a biological analysis device and a complementary receptacle |
| 12/27/2001 | US20010055799 Device for the preparation of biopsies for microscopic evaluation |
| 12/27/2001 | US20010055790 Genetically engineered proteins for use in the treatment of cancer, cardiovascular, neurological and developmental disorders |
| 12/27/2001 | US20010055785 Method of detecting procarboxypeptidase A and carboxypeptidase A levels in biological fluids |
| 12/27/2001 | US20010055784 Quantitative analysis |
| 12/27/2001 | US20010055783 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore |
| 12/27/2001 | US20010055781 Detection of eclampsia; obtain serum sample, monitor concentration of inhibin in sample |
| 12/27/2001 | US20010055780 Bacteriophage coupling to enzyme |
| 12/27/2001 | US20010055779 Competition assay for detecting compound-protein interactions in situ |
| 12/27/2001 | US20010055778 Screening sample for preferential immunoglobulin; incubate ligand, immunoglobulin and sample, incubate sample with immunoglobulin receptor, separate complexes, count carrier bond complexes |
| 12/27/2001 | US20010055776 High throughput cell-based assay kits |
| 12/27/2001 | US20010055774 Detecting particles which intensify a cells sensitivity to a enzymatic protein; incubate mutant cell with and without modulator, expose to stress, monitor cell for cell killing activity |
| 12/27/2001 | US20010055768 Multilayer; transparent support, thin metal film and intercalation compound containing nucleic acids |
| 12/27/2001 | US20010055764 Detecting ligand in sample; provide ligand on immobilized support, incubate with sample, detect bound complexes |
| 12/27/2001 | US20010055763 Detecting preferential particles in sample; label particles with lanthanide compounds and detect labeled particles by spectral emission |
| 12/27/2001 | US20010055762 Carrier for immobilizing biologically active substance |
| 12/27/2001 | US20010055758 Reagents and methods useful for detecting diseases of the prostate |
| 12/27/2001 | US20010055757 Specificity in the detection of anti-rubella IgM antibodies |
| 12/27/2001 | US20010055754 Quantitative analysis |
| 12/27/2001 | US20010055753 Method to regulate CD40 signaling |
| 12/27/2001 | US20010055752 Predictive assay for immune response |
| 12/27/2001 | US20010055751 PSCA: Prostate stem cell antigen and uses thereof |
| 12/27/2001 | US20010055544 Probe arm with multiple detectors for locating disaster and accident victims |
| 12/27/2001 | US20010055543 Dry analytical element |
| 12/27/2001 | US20010055542 Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity |
| 12/27/2001 | US20010055114 Fluorometry and fluorometric device and substrate suitable therefor |
| 12/27/2001 | US20010054900 Method and apparatus for identifying plastics |
| 12/27/2001 | US20010054580 Multiplex flow assays preferably with magnetic particles as solid phase |
| 12/27/2001 | US20010054308 Methods and apparatus for measuring suspended-substance concentrations |
| 12/27/2001 | US20010054304 Process for determining the current state of a lubricant |
| 12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |